BARMR1-mediated sorafenib resistance is derived through stem-like property acquisition by activating integrin-FAK signaling pathways
Open Access
- 12 June 2020
- journal article
- letter
- Published by Springer Science and Business Media LLC in Signal Transduction and Targeted Therapy
- Vol. 5 (1), 1-3
- https://doi.org/10.1038/s41392-020-0189-8
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Nuclear FAM289-Galectin-1 interaction controls FAM289-mediated tumor promotion in malignant gliomaJournal of Experimental & Clinical Cancer Research, 2019
- FAM92A1 is a BAR domain protein required for mitochondrial ultrastructure and functionThe Journal of cell biology, 2018
- Prokaryotic expression, purification of a new tumor-relative protein FAM92A1-289 and its characterization in renal cell carcinomaCancer Letters, 2009
- Identification and Characterization of Two Novel Variants of the DUF1208 Protein FAM92A1Molecules and Cells, 2007
- Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequencesProceedings of the National Academy of Sciences of the United States of America, 2002